Spironolactone Tablet, Film Coated
Product Images NDC 42708-101

4 FDA label images from Qpharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 42708-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Structure)

Image Description (Structure)
Chemical structure diagram of spironolactone, the active ingredient in the product Spironolactone 25 mg film-coated tablets by QPharma, Inc. The structure shows its steroid backbone with attached functional groups as illustrated in the molecular formula.*
FDA Label Image

Image Description (Figure 1)

Image Description (Figure 1)
A Kaplan-Meier survival curve showing the probability over time in months for two groups: one treated with Spironolactone (n=822) and a placebo group (n=841). The graph shows a higher probability for the Spironolactone group compared to placebo, with a significant log-rank p-value less than 0.001.*
FDA Label Image

Image Description (Figure 2)

Image Description (Figure 2)
A forest plot displaying hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups assessing the effect of Spironolactone compared to placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. Each subgroup shows the number of participants (N) and percentage (%) with corresponding HR and CI plotted on a horizontal axis ranging approximately from 0.2 to 1.4.*
FDA Label Image

Label (42708 101 30)

Label (42708 101 30)
Spironolactone Tablet USP, 25 mg, film-coated tablets in a package of 30 tablets. The label indicates this is a sample not for sale, with dosing instructions to be seen on the package insert. It is distributed by QPharma, Inc., Cedar Knolls, NJ 07927, and stored at controlled room temperature. The label also includes standard warnings about keeping the container tightly closed and out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.